Shanghai SIMR Biotechnology Co.,Ltd

中文 | EN

中文 EN

Expanded Access Policy Press Releases

Home > MEDIA

MEDIA

Expanded Access Policy

02 2020-09

SIMR completed the first-in-human study of candidate drug SR

Shanghai, China, June 12, 2020 ---- Shanghai SIMR Biotechnology Co., Ltd. (hereinafter referred to as "SIMR" or &qu...
10 2019-09

PharmaBoardroom interviews: Li Shuai – CEO, SIMR, China

Article Source：PharmaBoardroom Dr Li, could you share the story of how you decided to establish SIMR in 2014?I studied and worked in the Chinese Academy of Sciences (CAS) for 12 years, and during...
27 2019-07

SIMR initiated the first-in-human study of candidate drug SR

Shanghai, China, July 26, 2019 ---- Shanghai SIMR Biotechnology Co., Ltd. (hereinafter referred to as "SIMR" or &qu...
29 2018-05

The SPF animal facilities passed the on-site review

Recently, the SPF animal facilities have passed the on-site assessment and acceptance of experts from the Shanghai Science and Technology Commission....
25 2018-05

The people's Daily reported SIMR: Venture in Pudong, World c

The people's Daily reported on our company: Venture in Pudong, World close to usVenture in Pudong, World close to us----The people's Daily reported on our companyThe People's Daily is a daily newspaper in China. The paper is an official newspaper of the Chinese Communist Party, published worldwide with a circulation of......
18 2018-05

Shanghai Daily:In search of a new remedy for cancer pain

Shanghai DailyBy Qu Zhi | May 1, 2015, Friday | PRINT EDITIONLI Shuai founded a pharmaceutical company in Zhangjiang Hi-Tech Park in Pudong New Area over a year ago. The company has already tripled in size from a small laboratory of 100 square meters at the start.Li and his team have developed about 200 pharmaceutical......

Home Previous 1 2 3 4 Next Last

Previous Next Road 4 page 19 strip